Interleukin-24 therapy- a potential new strategy against liver fibrosis

• Anca D. Petrescu,
• Sharon DeMorrow

Affiliations

Anca D. Petrescu

Central Texas Veterans Health Care System, Temple, Texas; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas

Sharon DeMorrow

Central Texas Veterans Health Care System, Temple, Texas; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas; Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, Texas; Corresponding author.